Yep not manipulation. Just better places to park your money than a bio that has delivered nothing but loss in value for years running.
Not much depth before 5c mark. No news coming until Q1.
The question needs to be asked at the AGM, how does PAA justify the need for 4 directors with no epichem, dog trial complete, MND trial outsourced. What on earth are they doing besides taking a paycheck.
Why could we not go to 1 director, secretary and CEO?
FDA Application for Orphan Drug Designation , PAA, MPL, page-103
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $95.88M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $24.88K | 124.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6557 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 106840 | 6 |
View Market Depth
| Last trade - 11.23am 18/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |